The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The global Humira market was valued at US$ 17070 million in 2023 and is anticipated to reach US$ 9235.6 million by 2030, witnessing a CAGR of -8.3% during the forecast period 2024-2030.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
This report aims to provide a comprehensive presentation of the global market for Humira, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira.
Report Scope
The Humira market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Humira market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humira manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Eisai
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Humira manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Humira in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The global Humira market was valued at US$ 17070 million in 2023 and is anticipated to reach US$ 9235.6 million by 2030, witnessing a CAGR of -8.3% during the forecast period 2024-2030.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
This report aims to provide a comprehensive presentation of the global market for Humira, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira.
Report Scope
The Humira market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Humira market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humira manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Eisai
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Humira manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Humira in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Humira Market Overview
1.1 Product Overview and Scope of Humira
1.2 Humira Segment by Type
1.2.1 Global Humira Market Value Comparison by Type (2024-2030)
1.2.2 Humira Syringe
1.2.3 Humira Pen
1.3 Humira Segment by Application
1.3.1 Global Humira Market Value by Application: (2024-2030)
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn’s Disease
1.3.5 Others
1.4 Global Humira Market Size Estimates and Forecasts
1.4.1 Global Humira Revenue 2019-2030
1.4.2 Global Humira Sales 2019-2030
1.4.3 Global Humira Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Humira Market Competition by Manufacturers
2.1 Global Humira Sales Market Share by Manufacturers (2019-2024)
2.2 Global Humira Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Humira Average Price by Manufacturers (2019-2024)
2.4 Global Humira Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Humira, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Humira, Product Type & Application
2.7 Humira Market Competitive Situation and Trends
2.7.1 Humira Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Humira Players Market Share by Revenue
2.7.3 Global Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Humira Retrospective Market Scenario by Region
3.1 Global Humira Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Humira Global Humira Sales by Region: 2019-2030
3.2.1 Global Humira Sales by Region: 2019-2024
3.2.2 Global Humira Sales by Region: 2025-2030
3.3 Global Humira Global Humira Revenue by Region: 2019-2030
3.3.1 Global Humira Revenue by Region: 2019-2024
3.3.2 Global Humira Revenue by Region: 2025-2030
3.4 North America Humira Market Facts & Figures by Country
3.4.1 North America Humira Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Humira Sales by Country (2019-2030)
3.4.3 North America Humira Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Humira Market Facts & Figures by Country
3.5.1 Europe Humira Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Humira Sales by Country (2019-2030)
3.5.3 Europe Humira Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Humira Market Facts & Figures by Country
3.6.1 Asia Pacific Humira Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Humira Sales by Country (2019-2030)
3.6.3 Asia Pacific Humira Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Humira Market Facts & Figures by Country
3.7.1 Latin America Humira Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Humira Sales by Country (2019-2030)
3.7.3 Latin America Humira Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Humira Market Facts & Figures by Country
3.8.1 Middle East and Africa Humira Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Humira Sales by Country (2019-2030)
3.8.3 Middle East and Africa Humira Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Humira Sales by Type (2019-2030)
4.1.1 Global Humira Sales by Type (2019-2024)
4.1.2 Global Humira Sales by Type (2025-2030)
4.1.3 Global Humira Sales Market Share by Type (2019-2030)
4.2 Global Humira Revenue by Type (2019-2030)
4.2.1 Global Humira Revenue by Type (2019-2024)
4.2.2 Global Humira Revenue by Type (2025-2030)
4.2.3 Global Humira Revenue Market Share by Type (2019-2030)
4.3 Global Humira Price by Type (2019-2030)
5 Segment by Application
5.1 Global Humira Sales by Application (2019-2030)
5.1.1 Global Humira Sales by Application (2019-2024)
5.1.2 Global Humira Sales by Application (2025-2030)
5.1.3 Global Humira Sales Market Share by Application (2019-2030)
5.2 Global Humira Revenue by Application (2019-2030)
5.2.1 Global Humira Revenue by Application (2019-2024)
5.2.2 Global Humira Revenue by Application (2025-2030)
5.2.3 Global Humira Revenue Market Share by Application (2019-2030)
5.3 Global Humira Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Humira Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Humira Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Humira Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Cadila Healthcare
6.3.1 Cadila Healthcare Corporation Information
6.3.2 Cadila Healthcare Description and Business Overview
6.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cadila Healthcare Humira Product Portfolio
6.3.5 Cadila Healthcare Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Humira Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Humira Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Humira Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Samsung Bioepis
6.6.1 Samsung Bioepis Corporation Information
6.6.2 Samsung Bioepis Description and Business Overview
6.6.3 Samsung Bioepis Humira Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Samsung Bioepis Humira Product Portfolio
6.6.5 Samsung Bioepis Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Humira Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Humira Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Fresenius Kabi
6.8.1 Fresenius Kabi Corporation Information
6.8.2 Fresenius Kabi Description and Business Overview
6.8.3 Fresenius Kabi Humira Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fresenius Kabi Humira Product Portfolio
6.8.5 Fresenius Kabi Recent Developments/Updates
6.9 Celltrion
6.9.1 Celltrion Corporation Information
6.9.2 Celltrion Description and Business Overview
6.9.3 Celltrion Humira Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Celltrion Humira Product Portfolio
6.9.5 Celltrion Recent Developments/Updates
6.10 Coherus
6.10.1 Coherus Corporation Information
6.10.2 Coherus Description and Business Overview
6.10.3 Coherus Humira Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Coherus Humira Product Portfolio
6.10.5 Coherus Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Corporation Information
6.11.2 Sandoz Humira Description and Business Overview
6.11.3 Sandoz Humira Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sandoz Humira Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Torrent Pharmaceuticals
6.12.1 Torrent Pharmaceuticals Corporation Information
6.12.2 Torrent Pharmaceuticals Humira Description and Business Overview
6.12.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Torrent Pharmaceuticals Humira Product Portfolio
6.12.5 Torrent Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Humira Industry Chain Analysis
7.2 Humira Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Humira Production Mode & Process
7.4 Humira Sales and Marketing
7.4.1 Humira Sales Channels
7.4.2 Humira Distributors
7.5 Humira Customers
8 Humira Market Dynamics
8.1 Humira Industry Trends
8.2 Humira Market Drivers
8.3 Humira Market Challenges
8.4 Humira Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Humira Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Humira Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Humira Market Competitive Situation by Manufacturers in 2023
Table 4. Global Humira Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Humira Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Humira Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Humira Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Humira Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Humira, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Humira, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Humira, Product Type & Application
Table 12. Global Key Manufacturers of Humira, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Humira by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Humira Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Humira Sales by Region (2019-2024) & (K Units)
Table 18. Global Humira Sales Market Share by Region (2019-2024)
Table 19. Global Humira Sales by Region (2025-2030) & (K Units)
Table 20. Global Humira Sales Market Share by Region (2025-2030)
Table 21. Global Humira Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Humira Revenue Market Share by Region (2019-2024)
Table 23. Global Humira Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Humira Revenue Market Share by Region (2025-2030)
Table 25. North America Humira Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Humira Sales by Country (2019-2024) & (K Units)
Table 27. North America Humira Sales by Country (2025-2030) & (K Units)
Table 28. North America Humira Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Humira Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Humira Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Humira Sales by Country (2019-2024) & (K Units)
Table 32. Europe Humira Sales by Country (2025-2030) & (K Units)
Table 33. Europe Humira Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Humira Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Humira Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Humira Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Humira Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Humira Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Humira Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Humira Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Humira Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Humira Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Humira Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Humira Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Humira Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Humira Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Humira Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Humira Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Humira Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Humira Sales (K Units) by Type (2019-2024)
Table 51. Global Humira Sales (K Units) by Type (2025-2030)
Table 52. Global Humira Sales Market Share by Type (2019-2024)
Table 53. Global Humira Sales Market Share by Type (2025-2030)
Table 54. Global Humira Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Humira Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Humira Revenue Market Share by Type (2019-2024)
Table 57. Global Humira Revenue Market Share by Type (2025-2030)
Table 58. Global Humira Price (USD/Unit) by Type (2019-2024)
Table 59. Global Humira Price (USD/Unit) by Type (2025-2030)
Table 60. Global Humira Sales (K Units) by Application (2019-2024)
Table 61. Global Humira Sales (K Units) by Application (2025-2030)
Table 62. Global Humira Sales Market Share by Application (2019-2024)
Table 63. Global Humira Sales Market Share by Application (2025-2030)
Table 64. Global Humira Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Humira Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Humira Revenue Market Share by Application (2019-2024)
Table 67. Global Humira Revenue Market Share by Application (2025-2030)
Table 68. Global Humira Price (USD/Unit) by Application (2019-2024)
Table 69. Global Humira Price (USD/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Humira Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Eisai Corporation Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eisai Humira Product
Table 79. Eisai Recent Developments/Updates
Table 80. Cadila Healthcare Corporation Information
Table 81. Cadila Healthcare Description and Business Overview
Table 82. Cadila Healthcare Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Cadila Healthcare Humira Product
Table 84. Cadila Healthcare Recent Developments/Updates
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Amgen Humira Product
Table 89. Amgen Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Boehringer Ingelheim Humira Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Samsung Bioepis Corporation Information
Table 96. Samsung Bioepis Description and Business Overview
Table 97. Samsung Bioepis Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Samsung Bioepis Humira Product
Table 99. Samsung Bioepis Recent Developments/Updates
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Biocon Humira Product
Table 104. Biocon Recent Developments/Updates
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Fresenius Kabi Humira Product
Table 109. Fresenius Kabi Recent Developments/Updates
Table 110. Celltrion Corporation Information
Table 111. Celltrion Description and Business Overview
Table 112. Celltrion Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Celltrion Humira Product
Table 114. Celltrion Recent Developments/Updates
Table 115. Coherus Corporation Information
Table 116. Coherus Description and Business Overview
Table 117. Coherus Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Coherus Humira Product
Table 119. Coherus Recent Developments/Updates
Table 120. Sandoz Corporation Information
Table 121. Sandoz Description and Business Overview
Table 122. Sandoz Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sandoz Humira Product
Table 124. Sandoz Recent Developments/Updates
Table 125. Torrent Pharmaceuticals Corporation Information
Table 126. Torrent Pharmaceuticals Description and Business Overview
Table 127. Torrent Pharmaceuticals Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Torrent Pharmaceuticals Humira Product
Table 129. Torrent Pharmaceuticals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Humira Distributors List
Table 133. Humira Customers List
Table 134. Humira Market Trends
Table 135. Humira Market Drivers
Table 136. Humira Market Challenges
Table 137. Humira Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Humira
Figure 2. Global Humira Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Humira Market Share by Type in 2023 & 2030
Figure 4. Humira Syringe Product Picture
Figure 5. Humira Pen Product Picture
Figure 6. Global Humira Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Humira Market Share by Application in 2023 & 2030
Figure 8. Ankylosing Spondylitis
Figure 9. Rheumatoid Arthritis
Figure 10. Crohn’s Disease
Figure 11. Others
Figure 12. Global Humira Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Humira Market Size (2019-2030) & (US$ Million)
Figure 14. Global Humira Sales (2019-2030) & (K Units)
Figure 15. Global Humira Average Price (USD/Unit) & (2019-2030)
Figure 16. Humira Report Years Considered
Figure 17. Humira Sales Share by Manufacturers in 2023
Figure 18. Global Humira Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Humira Players: Market Share by Revenue in 2023
Figure 20. Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Humira Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Humira Sales Market Share by Country (2019-2030)
Figure 23. North America Humira Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Humira Sales Market Share by Country (2019-2030)
Figure 27. Europe Humira Revenue Market Share by Country (2019-2030)
Figure 28. Germany Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Humira Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Humira Revenue Market Share by Region (2019-2030)
Figure 35. China Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Humira Sales Market Share by Country (2019-2030)
Figure 45. Latin America Humira Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Humira Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Humira Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Humira Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Humira by Type (2019-2030)
Figure 55. Global Revenue Market Share of Humira by Type (2019-2030)
Figure 56. Global Humira Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Humira by Application (2019-2030)
Figure 58. Global Revenue Market Share of Humira by Application (2019-2030)
Figure 59. Global Humira Price (USD/Unit) by Application (2019-2030)
Figure 60. Humira Value Chain
Figure 61. Humira Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
